Articles with "lymphoma dlbcl" as a keyword



Photo from wikipedia

Therapy Strategy of CD47 in Diffuse Large B-Cell Lymphoma (DLBCL)

Sign Up to like & get
recommendations!
Published in 2021 at "Disease Markers"

DOI: 10.1155/2021/4894022

Abstract: At present, the use of the common chemotherapy regimen CHOP/R-CHOP for diffuse large B-cell lymphoma (DLBCL) has some shortcomings, especially for relapsed and refractory DLBCL. CD47 is now considered as a prominent target in cancer… read more here.

Keywords: lymphoma dlbcl; cd47; large cell; diffuse large ... See more keywords
Photo from wikipedia

High-resolution architecture and partner genes of MYC rearrangements in lymphoma with DLBCL morphology.

Sign Up to like & get
recommendations!
Published in 2018 at "Blood advances"

DOI: 10.1182/bloodadvances.2018023572

Abstract: Genomic rearrangements in the MYC locus occur in ∼12% of lymphomas with diffuse large B-cell lymphoma (DLBCL) morphology and are associated with inferior outcome. Previous studies exploring MYC rearrangements have primarily used fluorescence in situ… read more here.

Keywords: lymphoma dlbcl; partner; dlbcl morphology; myc rearrangements ... See more keywords
Photo from wikipedia

Diffuse Large B-Cell Lymphoma (DLBCL): Early Patient Management and Emerging Treatment Options

Sign Up to like & get
recommendations!
Published in 2022 at "OncoTargets and Therapy"

DOI: 10.2147/ott.s326632

Abstract: Abstract Diffuse large B-cell lymphoma (DLBCL) represents a curable disease with a 60–70% chance of cure with current R-CHOP chemoimmunotherapy. However, 30–40% of patients are refractory or relapsing. Many attempts failed to improve the outcome… read more here.

Keywords: cell; lymphoma; lymphoma dlbcl; cell lymphoma ... See more keywords
Photo from wikipedia

Epigenetic mechanisms of therapy resistance in diffuse large B cell lymphoma (DLBCL).

Sign Up to like & get
recommendations!
Published in 2021 at "Current cancer drug targets"

DOI: 10.2174/1568009620666210106122750

Abstract: Diffuse large B cell lymphoma (DLBCL) is the most common histological subtype of non-Hodgkin B cell lymphoma (NHL), and manifest highly heterogeneous genetic/phenotypic characteristics as well as variable responses to conventional immunochemotherapy (1). Genetic profiling… read more here.

Keywords: lymphoma dlbcl; cell; large cell; diffuse large ... See more keywords